Transplanted islets from lpr mice are resistant to autoimmune destruction in a model of streptozotocin-induced type I diabetes

Apoptosis

Volumn 10, Issue 4, 2005, Pages 725-730

  Vijayan, S ^a   Zhou, P ^a   Rajapaksha, T W ^a   Alegre, M L ^a   Peter, M E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; CD95; lpr; Type I diabetes

Indexed keywords

FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; INSULITIS; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; MUTATION; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; STREPTOZOCIN DIABETES; T LYMPHOCYTE; WILD TYPE;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED MRL LPR; STREPTOZOCIN;

EID: 23944507590     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-005-0377-6     Document Type: Article

References (25)

1. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-297.
2. Kagi D, et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 1997; 186: 989-997.
3. Chervonsky AV, et al. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.
4. Itoh N, et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 1997; 186: 613-618.
5. Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV. Contribution of Fas to diabetes development. Proc Natl Acad Sci USA 2003; 100: 628-632.
6. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 2000; 105: 459-468.
7. Moriwaki M, et al. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia 1999; 42: 1332-1340.
8. Yamada K, et al. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 1996; 39: 1306-1312.
9. Allison J, Strasser A. Mechanisms of beta cell death in diabetes: A minor role for CD95. Proc Natl Acad Sci USA 1998; 95: 13818-13822.
10. Kim S, et al. Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved. J Immunol 2000; 164: 2931-2936.
11. Apostolou I, Hao Z, Rajewsky K, von Boehmer H. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes. J Exp Med 2003; 198: 1103-1106.
12. Jin Y, et al. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin. Gene Ther 2004; 11: 982-991.
13. Zhang Y, et al. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol 2002; 168: 1466-1472.
14. van Halteren AG, Kardol MJ, Mulder A, Roep BO. Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia 2005; 48: 75-82.
15. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: More than an attraction. Immunity 1998; 9: 1-11.
16. Frigerio S, et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 2002; 8: 1414-1420.
17. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 2003; 171: 6838-6845.
18. Kim SH, Cleary MM, Fox HS, Chantry D, Sarvetnick N. CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest 2002; 110: 1675-1686.
19. Su X, et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 2000; 164: 2523-2532.
20. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 2003; 198: 1527-1537.
21. Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6: 920-923.
22. Desbarats J, et al. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 2003; 5: 118-125.
23. Barnhart BC, et al. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. Embo J 2004; 23: 3175-3185.
24. Mariani SM, Matiba B, Armandola EA, Krammer PH. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 1994; 24: 3119-3123.
25. Legembre P, et al. Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. EMBO Rep 2004; 5: 1084-1089.